Home > Press > Stony Brook University Researchers Develop Groundbreaking New Graphene-Based MRI Contrast Agent
Abstract:
Dr. Balaji Sitharaman, PhD, an Assistant Professor in the Department of Biomedical Engineering at Stony Brook University, and a team of researchers developed a new, highly efficacious, potentially safer and more cost effective nanoparticle-based MRI (magnetic resonance imaging) contrast agent for improved disease diagnosis and detection. The most recent findings are discussed in detail in his team's research paper "Physicochemical characterization, and relaxometry studies of micro-graphite oxide, graphene nanoplatelets, and nanoribbons," published in the June 7 edition of the journal PLoS ONE.
The MRI, the technology for which was invented at Stony Brook University by Professor Paul Lauterbur, is one of the most powerful and central techniques in diagnostic medicine and biomedical research used primarily to render anatomical details for improved diagnosis of many pathologies and diseases. Currently, most MRI procedures use gadolinium-based contrast agents to improve the visibility and definition of disease detection. However, recent studies have shown harmful side effects, such as nephrogenic systemic fibrosis, stemming from the use of this contrast agent in some patients, forcing the Food and Drug Administration (FDA) to place restrictions on the clinical use of gadolinium. Further, most MRI contrast agents are not suitable for extended-residence-intravascular (blood pool), or tissue (organ)-specific imaging, and do not allow molecular imaging.
To address the need for an MRI contrast agent that demonstrates greater effectiveness and lower toxicity, Dr. Sitharaman developed a novel high-performance graphene-based contrast agent that may replace the gadolinium-based agent which is widely used by physicians today. "A graphene-based contrast agent can allow the same clinical MRI performance at substantially lower dosages," said Dr. Sitharaman. The project is a Wallace H. Coulter Foundation Translational Research Award winner and the recipient of a two-year translational grant to study preclinical safety and efficacy.
"The technology will lower health care costs by reducing the cost per dose as well as the number of doses required," noted Dr. Sitharaman. "Further, since this new MRI contrast agent will substantially improve disease detection by increasing sensitivity and diagnostic confidence, it will enable earlier treatment for many diseases, which is less expensive, and of course more effective for diseases such as cancer."
The new graphene-based imaging contrast agent is also the focus of Dr. Sitharaman's start-up company, Theragnostic Technologies, Inc., which was incorporated in early 2012. The ongoing development of this technology is supported by industry expert and business advisor, Shahram Hejazi, and clinical experts Kenneth Shroyer, MD, PhD, Professor and Chair, Department of Pathology, Stony Brook University, and William Moore, MD, Chief of Thoracic Imaging, and Assistant Professor, Department of Radiology, Stony Brook University. Co-authors of the article include Department of Biomedical Engineering research assistants Bhavna Paratala, Barry Jacobson and Shruti Kanakia; and Leonard Deepak Francis from the International Iberian Nanotechnology Laboratory in Portugal.
Dr. Sitharaman's research team focuses their interests at the interface of bionanotechnology, regenerative and molecular medicine. They seek to "synergize" the advancements in each of these fields to develop a dynamic research program that tackles problems related to the diagnosis and treatment of disease and tissue regeneration. Dr. Sitharaman received his BS with Honors from the Indian Institute of Technology and his PhD from Rice University, where he also completed his postdoctoral work as a J. Evans Attwell-Welch Postdoctoral Fellowship recipient.
####
For more information, please click here
Contacts:
Stony Brook University Office of Media Relations
631.632.6310
Copyright ? Newswise
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
News and information
Fifteen Students Graduate from Innovative 'NanoHigh' Program Presented by CNSE & CSDA: Number of graduates reaches 90 as first-of-its-kind initiative marks 5th anniversary, with participation set to triple for next year?s program June 7th, 2012
Slow release technology helps aromatic fragrance industry June 7th, 2012
Nanostart AG publishes numbers for fiscal year 2011: Transparency report in accordance with ?17 Sect. 2 of commercial code for the OTC market. June 7th, 2012
CU-Boulder physicists use ultrafast lasers to create first tabletop X-ray device June 7th, 2012
Raman Microspectroscopy Now Offered On Many Optical Microscopes by CRAIC Technologies June 7th, 2012
Imaging
CU-Boulder physicists use ultrafast lasers to create first tabletop X-ray device June 7th, 2012
Raman Microspectroscopy Now Offered On Many Optical Microscopes by CRAIC Technologies June 7th, 2012
High-Vacuum Positioning Systems Brochure from PI miCos June 6th, 2012
Tighter 'stitching' means better graphene, say scientists June 4th, 2012
Graphene
'Nanocable' could be big boon for energy storage: Rice University's coaxial nanocable outperforms previous microcapacitors June 7th, 2012
Tighter 'stitching' means better graphene, say scientists June 4th, 2012
Nanomedicine
Fifteen Students Graduate from Innovative 'NanoHigh' Program Presented by CNSE & CSDA: Number of graduates reaches 90 as first-of-its-kind initiative marks 5th anniversary, with participation set to triple for next year?s program June 7th, 2012
Applied nanobiomedicine: Exploiting nanoparticles to hunt for hidden cancer cells June 7th, 2012
Nanomedicines promise fewer side effects in treating cancer June 6th, 2012
Arrowhead Research Advances ARC-520 into IND-Enabling Studies for theTreatment of Hepatitis B and Provides Guidance on Development Timeline June 6th, 2012
Discoveries
Slow release technology helps aromatic fragrance industry June 7th, 2012
CU-Boulder physicists use ultrafast lasers to create first tabletop X-ray device June 7th, 2012
'Nanocable' could be big boon for energy storage: Rice University's coaxial nanocable outperforms previous microcapacitors June 7th, 2012
Applied nanobiomedicine: Exploiting nanoparticles to hunt for hidden cancer cells June 7th, 2012
Announcements
FEI Receives Bookings Worldwide from Oil & Gas Companies: FEI?s Core-to-Pore workflow and QEMSCAN WellSite solution are helping oil & gas companies and service providers with better reservoir characterization for production optimization June 7th, 2012
'Nanocable' could be big boon for energy storage: Rice University's coaxial nanocable outperforms previous microcapacitors June 7th, 2012
Applied nanobiomedicine: Exploiting nanoparticles to hunt for hidden cancer cells June 7th, 2012
Asylum Research Appoints Spectra Research Corp. as its Exclusive Canadian Distributor June 7th, 2012
sovereign citizen komen chrome for android hatchet leah messer freedom riders 9th circuit court of appeals
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.